Study Demonstrated 87% Overall Response Rate in Metastatic Prostate Cancer Patients Treated with SYNC-T, a First-in-Class In Situ Personalized Immunotherapy...
The Annual General Meeting 2025 of RaySearch Laboratories AB (publ) was held on May 22, 2025, in Stockholm, Sweden. The following...
CENTER VALLEY, Pa., May 22, 2025 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives...
Los Angeles, California--(Newsfile Corp. - May 22, 2025) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer...
This release corrects and replaces the press release issued by Mobile-health Network Solutions on May 20, 2025 at 8:30 AM EDT. The...
CHATHAM, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company with marketed...
• BLA priority review of RP1 plus nivolumab in advanced melanoma proceeding on schedule; manufacturing inspections and late cycle review...
The Clinical Study Is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites...
MENLO PARK, Calif., May 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
Healthcare technology leader Dr. Gregory Sorensen joins Board of Directors; Defense expert Col. (Ret.) Gregory Van Dyk joins as Strategic...
ALEXANDRIA, Va., and SUNNYVALE, Calif., May 21, 2025 /PRNewswire/ -- The American Society of Clinical Oncology (ASCO) and Google Cloud today...
CHICAGO, May 21, 2025 /PRNewswire/ -- The global AI In Healthcare Market size is projected to be valued at USD 26.6 Billion in 2024...
CHICAGO, May 21, 2025 /PRNewswire/ -- The global Artificial Intelligence in Diagnostics Market Size is projected to be valued at USD 1.97...
RAMSEY, N.J., May 21, 2025 /PRNewswire/ -- Comport Consulting Corp., a trusted partner in delivering innovative technology solutions for the healthcare...
VIENNA, May 21, 2025 /PRNewswire/ -- Lexogen, a leader in RNA sequencing technologies, is excited to announce the launch of...
Seasoned diagnostics executive brings expertise in financial strategy and operational infrastructure development across diagnostics and Medtech industries BRISBANE, Calif., May...
Renowned oncologist and translational researcher to spearhead medical strategy as company scales innovative lifestyle modification modelNEW YORK, May 21, 2025...
PHM23 was one of a handful of molecules chosen by the universityBird Flu helping PHM23 gain awareness of broad-spectrum activity...
Silexion’s new groundbreaking study explores the potential impact of its next generation RNAI therapeutic candidate beyond pancreatic cancer aiming to...
Represents significant milestone in the development of KAD101, a novel biologic prolactin receptor antagonist, being initially developed for the treatment...